article thumbnail

Investigating Etoposide Adverse Reactions Associated with Polyethersulfone Filter

Pharmacy Times

This study showed the importance of a multidisciplinary team’s expertise to investigate a clinical inquiry beyond the scope of the clinicians’ skillset and their access to necessary technology.

article thumbnail

FDA, Novo Nordisk Warn of Counterfeit Semaglutide Injection Pens

Pharmacy Times

A counterfeit medication was reportedly purchased at a retail pharmacy, appearing to have contained another type of diabetes medication that led to an adverse reaction.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Drug safety update says fluoroquinolone antibiotics should be last resort

Hospital Pharmacy Europe

Reports of serious adverse reactions to fluoroquinolone antibiotics have included tendinitis or tendon rupture, muscle pain, muscle weakness, joint pain, joint swelling, peripheral neuropathy and central nervous system effects. Fluoroquinolones use should be discontinued at the first signs of a serious adverse reaction.

article thumbnail

Amyloid-Targeting Class of Alzheimer Disease Drugs Show Potential, Raise Concerns of Accessibility for Diverse Patients

Pharmacy Times

Advancements in the development of amyloid-targeting monoclonal antibodies show promise for treating Alzheimer disease, but there have been concerns around cost, adverse reactions, and inequity of care for marginalized patients.

article thumbnail

Managing Adverse Events Associated with HE Therapies

Pharmacy Times

Riello, PharmD, BCPS, discusses the adverse events associated with hepatic encephalopathy (HE) treatments and the importance of encouraging patients to continue first-line medications despite adverse reactions to prevent HE recurrence.

article thumbnail

Rare MIS-C Does Not Appear to Impact COVID-19 Vaccine Safety in Children

Pharmacy Times

Children who experienced COVID-19-induced multisystem inflammatory syndrome did not experience severe adverse reactions following COVID-19 vaccination.

article thumbnail

Decades-long regulatory odyssey ends with FDA nod for Fabre-Kramer's depression med Exxua

Fierce Pharma

Its label doesn't include sexual dysfunction as an adverse reaction, which is rare among antidepressants. . | Fabre-Kramer's Exxua suffered three prior FDA rejections before scoring an FDA approval for major depressive disorder last week.